PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsLevobupivacaine
Levobupivacaine
Chirocaine (levobupivacaine) is a small molecule pharmaceutical. Levobupivacaine was first approved as Chirocaine on 1999-08-05. It is used to treat pain in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
signs and symptoms pathological conditionsD013568
psychological phenomenaD011579
musculoskeletal and neural physiological phenomenaD055687
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Levobupivacaine hydrochloride
Tradename
Company
Number
Date
Products
CHIROCAINEPurdue PharmaN-020997 DISCN1999-08-05
3 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
0.25% bupivacaine hcl bupivacaine hydrochlorideANDA2024-06-20
blt-25 kitunapproved drug other2024-09-11
bupivacaineANDA2024-10-25
bupivacaine hciANDA2024-01-22
bupivacaine hci and epinephrineANDA2024-01-30
bupivacaine hclNew Drug Application2024-01-27
bupivacaine hcl bupivacine hclANDA2023-06-09
bupivacaine hydrochlorideANDA2024-11-04
bupivacaine hydrochloride and epinephrineANDA2024-10-14
bupivacaine hydrochloride bupivacaine hydrochloride and epinephrineANDA2024-10-15
Show 63 more
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
painEFO_0003843D010146R52
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
N: Nervous system drugs
N01: Anesthetics
N01B: Local anesthetics
N01BB: Amide local anesthetics
N01BB10: Levobupivacaine
HCPCS
No data
Clinical
Clinical Trials
3904 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Postoperative painD010149G89.18471311052576741166
PainD010146EFO_0003843R52717177390201
AnalgesiaD000698681334132190
AnesthesiaD00075841092687131
Bone fracturesD050723EFO_0003931T14.87782572116
Acute painD059787R5241292764109
Local anesthesiaD000772676166699
Replacement arthroplasty kneeD019645141404389
HerniaD006547HP_0100790K40-K46497155688
Spinal anesthesiaD000775236255388
Show 397 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HerniorrhaphyD0596851326
Postherpetic neuralgiaD0514741135
LaminectomyD007796134
Post-traumatic headacheD051298G44.31124
RhinosinusitisD0000968251213
Postoperative cognitive complicationsD000079690123
Headache disordersD020773EFO_0009550G44123
Radical mastectomyD0154091123
Nasal polypsD009298HP_0100582J33112
Blood coagulation disordersD001778EFO_0009314D68.9112
Show 38 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Urinary bladder neoplasmsD001749C67178
Respiratory insufficiencyD012131HP_0002093J96.9145
Hiv infectionsD015658EFO_0000764B2044
InfectionsD007239EFO_0000544213
AnxietyD001007EFO_0005230F41.1123
VaginismusD052065N94.2112
Covid-19D000086382112
Pudendal neuralgiaD060545112
AdenomyosisD062788EFO_1001757N80.0112
Primary dysautonomiasD05496922
Show 27 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ThoracotomyD0139081212
NephrectomyD00939277
ArthroscopyD00118277
IschemiaD007511EFO_000055666
Acalculous cholecystitisD042101EFO_100079066
Acute cholecystitisD041881EFO_1001289K81.055
Congenital abnormalitiesD000013EFO_0003915Q89.944
Kidney diseasesD007674EFO_0003086N0844
Breast diseasesD001941N60-N6544
Rheumatoid arthritisD001172EFO_0000685M06.944
Show 241 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameLevobupivacaine
INNlevobupivacaine
Description
Levobupivacaine is the (S)-(-)-enantiomer of bupivacaine. It has a role as a local anaesthetic, an adrenergic antagonist, an amphiphile, an EC 3.1.1.8 (cholinesterase) inhibitor and an EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor. It is a conjugate base of a levobupivacaine(1+). It is an enantiomer of a dextrobupivacaine.
Classification
Small molecule
Drug classlocal anesthetics
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C
Identifiers
PDB
CAS-ID27262-47-1
RxCUI
ChEMBL IDCHEMBL1201193
ChEBI ID6149
PubChem CID92253
DrugBankDB01002
UNII IDA5H73K9U3W (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 26,951 documents
View more details
Safety
Black-box Warning
Black-box warning for: 0.25% bupivacaine hcl bupivacaine hydrochloride, Blt-25 kit, Bupivacaine hci, Bupivacaine hcl, Bupivacaine hcl bupivacine hcl, Bupivacaine hydrochloride, Bupivacaine hydrochloride and epinephrine, Bupivacaine hydrochloride bupivacaine hydrochloride and epinephrine, Bupivacaine hydrochloride injection, solution, Bupivilog kit, Dexlido-m kit, Dyural 40 kit, Dyural 80 kit, Dyural 80-lm, Dyural lm kit, Ketorocaine lm kit, Marbeta 25 kit, Marbeta l kit, Marcaine, Marcaine marcaine with epinephrine, Marcaine with epinephrine, Mardex 25 kit, Marlido 25 kit, Marlido kit, Marvona suik, Mlk f1 kit, Mlk f3 kit, Mlk f4 kit, Mlk kit f2, Physicians ez use m-pred, Posimir, Readysharp anesthetics plus ketorolac, Sensorcaine mpf, Sensorcaine sensorcaine, Sensorcaine sensorcaine-mpf sensorcaine-mpf, Sensorcaine(r) (bupivacaine hci and epinephrine), Sensorcaine-mpf, Zynrelef
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
13,428 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use